Literature DB >> 6995315

Fungicidal activity of rabbit alveolar and peritoneal macrophages against Candida albicans.

R I Lehrer, L G Ferrari, J Patterson-Delafield, T Sorrell.   

Abstract

We tested the ability of rabbit macrophages to kill Candida albicans in vitro. Resident (unstimulated) alveolar macrophages killed 28.1 +/- 1.9% of ingested organisms in 4 h, whereas resident peritoneal macrophages killed only 15.2 +/- 1.3% (mean +/- standard error of the mean, P < 0.01). Peritoneal macrophages obtained from rabbits treated 3 weeks earlier with complete Freund adjuvant showed enhanced candidacidal activity relative to normally resident peritoneal cells (28.2 +/- 3.1%, P < 0.01). Candidacidal activity by alveolar macrophages recovered from such treated animals was slightly enhanced relative to untreated alveolar macrophages (32.9 +/- 2.3%). Candidacidal activity by peritoneal and alveolar macrophages was not decreased by several agents (cyanide, azide, sulfadiazine, and phenylbutazone) that inhibit the ability of human blood monocytes to kill C. albicans. In contrast, candidacidal activity by alveolar macrophages was greatly diminished by iodoacetate, an ineffective inhibitor of this function in human monocytes. We conclude that rabbit macrophages kill C. albicans by a fungicidal mechanism distinct from the peroxidase-H2O2 mechanism of human granulocytes and monocytes, and that the fungicidal properties of peritoneal and alveolar macrophage populations are enhanced after nonspecific stimulation with complete Freund adjuvant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995315      PMCID: PMC551049          DOI: 10.1128/iai.28.3.1001-1008.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  The role of macrophages in Candida albicans infection in vitro.

Authors:  K Ozato; I Uesaka
Journal:  Jpn J Microbiol       Date:  1974-01

2.  Peroxidase mediated antimicrobial activities of alveolar macrophage granules.

Authors:  B B Paul; R R Strauss; R J Selvaraj; A J Sbarra
Journal:  Science       Date:  1973-08-31       Impact factor: 47.728

3.  The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

Review 4.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

5.  Inhibition of specific amino acid uptake in Candida albicans by lysosomal extracts from rabbit alveolar macrophages.

Authors:  E M Peterson; R A Calderone
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

6.  Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen.

Authors:  T C Sorrell; R I Lehrer; M J Cline
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

7.  Functional aspects of a second mechanism of candidacidal activity by human neutrophils.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  Function of h(2)o(2), myeloperoxidase, and hexose monophosphate shunt enzymes in phagocytizing cells from different species.

Authors:  B B Paul; R R Strauss; A A Jacobs; A J Sbarra
Journal:  Infect Immun       Date:  1970-04       Impact factor: 3.441

10.  Metabolic event involved in the bactericidal activity of normal mouse macrophages.

Authors:  T E Miller
Journal:  Infect Immun       Date:  1971-03       Impact factor: 3.441

View more
  32 in total

1.  Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1.

Authors:  E Blasi; S Farinelli; L Varesio; F Bistoni
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

Review 2.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

3.  Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages.

Authors:  D L Granger; J B Hibbs; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  In vivo determination of phagocytic indices and candidacidal activities of Candida species by rat peritoneal macrophages.

Authors:  R Salim; A van Gelderen de Komaid
Journal:  Mycopathologia       Date:  1986-07       Impact factor: 2.574

5.  Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans.

Authors:  T Decker; M L Lohmann-Matthes; M Baccarini
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

6.  Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxide-iodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system.

Authors:  S M Levitz; R D Diamond
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

Review 7.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

8.  Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.

Authors:  N P Cummings; M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

9.  Killing of Aspergillus spores depends on the anatomical source of the macrophage.

Authors:  A Schaffner; H Douglas; A I Braude; C E Davis
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Increase of mouse resistance to Candida albicans infection by thymosin alpha 1.

Authors:  F Bistoni; P Marconi; L Frati; E Bonmassar; E Garaci
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.